ABO blood group: Old dogma, new perspectives

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 8, 2013, Pages 1545-1553

  Franchini, Massimo ^a   Liumbruno, Giancarlo Maria ^b  

^a CARLO POMA HOSPITAL   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

ABO blood group; cancer; cardiovascular disorders; thrombosis; von Willebrand factor

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; VON WILLEBRAND FACTOR;

AGGLUTINATION TEST; BIOCHEMISTRY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ERYTHROCYTE; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HISTORY; HUMAN; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 84883025009     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0168     Document Type: Review

References (60)

1. Storry JR, Olsson ML. The ABO blood group system revisited: A review and update. Immunohematology 2009;25:48-59
2. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998;38:975-88 (Pubitemid 28467227)
3. Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Relationship between ABO blood group and von Willebrand factor levels: From biology to clinical implications. Thromb J 2007;5:14
4. Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012;49:137-49
5. Landsteiner K. Zur kenntnis der antifermentativen, lytischen und agglutinierenden wirkungendes des blutserums und der lymphe. Zentralbl Bakteriol 1900;27:357-63
6. Decastello A, Sturli A. Ü ber die isoagglutinine im serum gesunder und kranker menschen. Munch Med Wochenschr 1902;49:1900-5
7. Springer GF. Blood-group and Forssman antigenic determinants shared between microbes and mammalian cells. Prog Allergy 1971;15:9-77
8. Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka A, Scheinberg P, et al. Probiotic-Associated high-Titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845-9
9. Cooling L. ABO, H, and Lewis blood groups and structurally related antigens. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical manual, 17th ed. Bethesda: AABB, 2011:363-87
10. Napier JAF, editor. Handbook of blood transfusion therapy, 2nd ed. Chichester: John Wiley & Sons Ltd, 1995:15
11. Mollison PL, Engelfriet CP, Contreras MK, editors. Blood transfusion in clinical medicine, 9th ed. Oxford: Blackwell Scientific Publications, 1993:150
12. Bloodbook.com. Racial and ethnic distribution of ABO blood types. Available from: Http://www.bloodbook.com/world-Abo. html. Accessed on 3 April, 2013
13. Lin-Chu M, Broadberry RE, Chang FJ. The distribution of blood group antigens and alloantibodies among Chinese in Taiwan. Transfusion 1988;28:350-2
14. Lalueza-Fox C, Gigli E, de la Rasilla M, Fortea J, Rosas A, Bertranpetit J, et al. Genetic characterization of the ABO blood group in Neandertals. BMC Evol Biol 2008;8:342
15. Crainic K, Durigon M, Oriol R. ABO tissue antigens of Egyptian mummies. Forensic Sci Int 1989;43:113-24 (Pubitemid 19275361)
16. Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, Green A, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 2007;17:567-76
17. Borén T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892-5 (Pubitemid 24041864)
18. Swerdlow DL, Mintz ED, Rodriguez M, Tejada E, Ocampo C, Espejo L, et al. Severe life-Threatening cholera associated with blood group O in Peru: Implications for the Latin American epidemic. J Infect Dis 1994;170:468-72 (Pubitemid 24226385)
19. Yamamoto F. Review: ABO blood group system-ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 2004;20:3-22 (Pubitemid 38292744)
20. Schiff F, Sasaki H. Der Ausscheidungstypus ein auf Serologischem Wege Nachweirbares Mendelndes merkaml. Klin Wochenschr 1932;11:1426-9
21. Kelly RJ, Ernst LK, Larsen RD, Bryant JG, Robinson JS, Lowe JB. Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals. Proc Natl Acad Sci USA 1994;91:5843-7
22. Bhende YM, Deshpande CK, Bhatia HM, Sanger R, Race RR, Morgan WT, et al. A " new " blood group character related to the ABO system. Lancet 1952;1:903-4
23. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-33
24. Kermarrec N, Roubinet F, Apoil PA, Blancher A. Comparison of allele O sequences of the human and non-human primate ABO system. Immunogenetics 1999;49:517-26 (Pubitemid 29221784)
25. Beattie KM. Discrepancies in ABO grouping. In: American Association of Blood Banks, editor. A seminar on problems encountered in pretranfusion tests. Washington, DC: American Association of Blood Banks, 1972: 129-65
26. Hosoi E. Biological and clinical aspects of ABO blood group system. J Med Invest 2008;55:174-82
27. International Society of Blood Transfusion (ISBT). Blood Group Terminology. Table of blood group systems. Available from: Http://www.isbtweb. org/fileadmin/user-upload/ WP-on-Red-Cell-Immunogenetics-and/Table-of-blood- group-systems-v3.0-121028.pdf. Accessed on 2 March, 2013
28. SocietéItaliana di Medicina Trasfusionale e Immunoematologia (SIMTI), editor. Standards of Transfusion Medicine, 2nd ed. Milan: SIMTI Servizi srl, 2010:156. Available from: Http://www. simti.it/pdf/Standard-EN-protetto. pdf. Accessed 2 Mar, 2013
29. Gerbal A, Maslet C, Salmon C. Immunologic aspects of the acquired-B antigen. Vox Sang 1975;28:398-403
30. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have " high-Titer " anti-A/A,B: Implications for transfusion policy. Transfusion 2004;44:805-8 (Pubitemid 38738406)
31. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovéan R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher 2005;20:225-9
32. Bolton-Maggs PH, editor, Cohen H, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report (2012). Available from: Http://www.shotuk. org/wp-content/uploads/2012/07/SHOT-ANNUAL-REPORT- FinalWebVersionBookmarked-2012-06-22.pdf. Accessed on 4 April, 2013
33. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009;7:132-50
34. Cooling L. ABO and platelet transfusion therapy. Immunohematology 2007;23:20-33 (Pubitemid 46608792)
35. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion of red blood cells. Blood Transfus 2009;7:49-64
36. Tormey CA. Transfusion support for hematopoietic stem cell transplant recipients. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical manual, 17th ed. Betheshda: AABB, 2011:687-705
37. Yazer MH, Triulzi DJ. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 2007;14:664-70 (Pubitemid 47494084)
38. Sassi M, Maggiore U, Buzio C, Franchini M. Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy. Blood Transfus 2011;9:218-24
39. Clarke CA. Blood group and disease. In: Steiberg AG, editor. Progress in medical genetics, Vol. 1. New York: Grune and Stratton, 1961:81-119
40. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: A cohort study. Am J Epidemiol 2010;172:1280-5
41. Wang Z, Liu L, Ji J, Zhang J, Yan M, Zhang J, et al. ABO blood group system and gastric cancer: A case-control study and meta-Analysis. Int J Mol Sci 2012;13:13308-31
42. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90
43. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-31
44. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: A case-control study. J Natl Cancer Inst 2010;102:502-5
45. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PloS One 2010;5:e11972
46. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011;128:482-6
47. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, et al. Expression of blood-group antigen A-A favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084-90
48. Khalili H, Wolpin BM, Huang ES, Giovannucci EL, Kraft P, Fuchs CS, et al. ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1017-29
49. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer 2012;130:2129-37
50. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol 1964;10:238-45
51. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001;41:56-60 (Pubitemid 32142246)
52. O Donnell JS, Lasffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001;11:343-51
53. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-5 (Pubitemid 17091627)
54. Matsui T, Titani K, Mizuochi T. Structures of the asparaginelinked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 1992;267:8723-31
55. Sodetz JM, Pizzo SV, McKee PA. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 1977;252:5538-46 (Pubitemid 8167004)
56. Jenkins PV, O Donnell JS. ABO blood group determines plasma von Willebrand factor levels: A biologic function after all? Transfusion 2006;46:1836-44 (Pubitemid 44435738)
57. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: A systematic review and meta-Analysis. J Thromb Haemost 2008;6:62-9
58. Dentali F, Sironi AP, Ageno W, Turato S, Bonfanti C, Frattini F, et al. Non-O blood type is the commonest genetic risk factor for VTE: Results from a meta-Analysis of the literature. Semin Thromb Hemost 2012;38:535-48
59. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012;32:2314-20
60. Franchini M, Rossi C, Mengoli C, Frattini F, Crestani S, Giacomini I, et al. ABO blood group and the risk of coronary artery disease. J Thromb Thrombolysis 2012; DOI: 10.1007/s11239-012-0836-1